Zoetis Inc (NYSE:ZTS)
$ 168.21 -0.83 (-0.49%) Market Cap: 76.75 Bil Enterprise Value: 81.85 Bil PE Ratio: 32.41 PB Ratio: 15.20 GF Score: 96/100

Zoetis Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 08:15PM GMT
Release Date Price: $117.2 (+0.15%)
Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst

© -

Great. Thanks. Good afternoon, everybody. My name is Erin Wright. I cover Life Science Tools Diagnostics at Crédit Suisse. We're happy to have Zoetis with us today. With them, we have Glenn David, the EVP and CFO; as well as Kristin Peck, who is -- well, upcoming CEO as well as EVP of U.S. Operations as, well as wearing several different -- many hats at Zoetis. So we're really happy to have you here today. Sorry, hopefully, you're not getting too much feedback here.

Questions & Answers

Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst

© -

And just with that, given your recent announcement, I did want to ask kind of any sort of changes in strategy here? Any shifts with sort of the CEO transition that we should be anticipating? I know you've sent the IPO process, and I know you've done several different roles within Strategy,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot